A Canadian medical marijuana producer announced a stock-purchase deal to raise 30 million Canadian dollars ($24 million) in capital, which it intends to apply to research and development. After the deal closes later this month, Cronos will have raised more than CA$120 million since the beginning of 2017, including CA$40 million in debt. Stayner, Ontario-based […]
Cronos signs deal to secure CA$30 million for marijuana R&D is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs
Read More: Cronos signs deal to secure CA million for marijuana R&D
Comments are closed, but trackbacks and pingbacks are open.